Read-across and UVCB
Looking to build your skills in carrying out a read-across on UVCB substances? Join and foster our In silico Toxicology Community in the UK and beyond and participate to our Networking Meeting 2019 which will be held on the 26th of November 2019 in Cambridge. Elena will present "New Approach Methodologies in Read-Across for Toxicity Prediction: a Workflow Based on Cheminformatics" with a section dedicated to UVCBs. If you you cannot be at this meeting and you are still interested in read-across in general or in particular applied to UVCB substances, drop Elena an email to have a copy of her presentation: email@example.com.
The program of the meeting is dedicated to various aspects of computational toxicology. You will hear about risk assessment for consumer products (Steve Gutsell, Unilever/SEAC), drug safety and metabolism (Graham Smith, AstraZeneca), molecular initiating events (Jonathan Goodman, University of Cambridge), computational chemistry in toxicology (Tim Allen, MRC Toxicology Unit), hepatotoxicity and acute toxicity (Samar Mahmoud, University of Cambridge/Optibrium), translational toxicology (Aishling Cooke, Optibrium), adverse outcome pathway (Alun Myden, Lhasa Ltd), androgen receptor activity (Barry Hardy/Thomas Exner, EdelweissConnect) and a final discussion 'Artificial Intelligence in Computational Toxicology - What works currently, what is needed, and what will the future bring?'
This event is organized by Andreas Bender (Co-Founder and Advisor at Healx Ltd) and supported by the British Toxicology Society (BTS), the Royal Society of Chemistry (RSC) CICAG Group, the Cambridge Alliance on Medicines Safety (CAMS) and Lhasa Ltd.